Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

Direct Payment

$120,000.00

Investigating the Developmental Origins of HIF-2a-Driven Paragangliomas

FY 2025-26

Summary
In inherited cancers, DNA in every cell of the body contains the cancer-causing mutation. However, the tumours that form later in life are almost always localized to a specific tissue, and the developmental origins of such tumours remain poorly understood by cancer biologists. For example, if a person inherits a cancer-causing mutation to the BRCA gene, they will almost exclusively develop breast or ovarian cancer. We are interested in tissue-specific tumours called paragangliomas that occur in hormone-secreting cells of the body's nervous system. These tumours are driven by mutations in the genes responsible for the response to low oxygen (hypoxia). Nearly 40% of paragangliomas are caused by inherited mutations, which cause cells to behave as if oxygen is scarce, even when it is not. We have hypothesized that this constant 'pseudohypoxia' through one's lifetime leads to the presence of abnormal nervous system cells. Within these abnormal cells, the CCND1 gene is activated, which is thought to trigger tumour growth. We aim to identify the mechanism linking this overactive hypoxic response with abnormal development and cancer, and further understand if exposure to low oxygen environments, such as high altitude, may predispose individuals to tumours. To accomplish these research goals, we will mutate paraganglioma-related genes in mice. We will track the tissue changes and tumour development in these mouse models using genetic sequencing and specialized microscopy techniques. Finally, we will test the use of clinically licensed drugs in blocking tumour growth by targeting the genes responsible for the hypoxia response or the CCND1 gene. This work will provide direct evidence for how an overactive response to low oxygen drives tissue-specific neuroendocrine cancer. By clarifying early events in the formation of these tumours, our research will advance fundamental understanding of cancer proliferation and inform new strategies for precision therapy and prevention.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
553051
Name
Mallard Claire M
Country
United Kingdom
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating the Developmental Origins of HIF-2a-Driven Paragangliomas
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Hereditary Mutations; Histology; Hypoxia; Oncogenesis; Oxygen Sensing; Paraganglioma; Physiology; Rna-Seq; Sympatho-Adrenal System
Abstract
In inherited cancers, DNA in every cell of the body contains the cancer-causing mutation. However, the tumours that form later in life are almost always localized to a specific tissue, and the developmental origins of such tumours remain poorly understood by cancer biologists. For example, if a person inherits a cancer-causing mutation to the BRCA gene, they will almost exclusively develop breast or ovarian cancer. We are interested in tissue-specific tumours called paragangliomas that occur in hormone-secreting cells of the body's nervous system. These tumours are driven by mutations in the genes responsible for the response to low oxygen (hypoxia). Nearly 40% of paragangliomas are caused by inherited mutations, which cause cells to behave as if oxygen is scarce, even when it is not. We have hypothesized that this constant 'pseudohypoxia' through one's lifetime leads to the presence of abnormal nervous system cells. Within these abnormal cells, the CCND1 gene is activated, which is thought to trigger tumour growth. We aim to identify the mechanism linking this overactive hypoxic response with abnormal development and cancer, and further understand if exposure to low oxygen environments, such as high altitude, may predispose individuals to tumours. To accomplish these research goals, we will mutate paraganglioma-related genes in mice. We will track the tissue changes and tumour development in these mouse models using genetic sequencing and specialized microscopy techniques. Finally, we will test the use of clinically licensed drugs in blocking tumour growth by targeting the genes responsible for the hypoxia response or the CCND1 gene. This work will provide direct evidence for how an overactive response to low oxygen drives tissue-specific neuroendocrine cancer. By clarifying early events in the formation of these tumours, our research will advance fundamental understanding of cancer proliferation and inform new strategies for precision therapy and prevention.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mallard, Claire M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
Direct Payment - $120,000 Grant (2025-26) | Canada Spends